Description

Ethyl 2-Amino-3-(1,3-benzothiazol-2-yl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-carboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value in medicinal chemistry research and development, serving as a critical building block for novel active pharmaceutical ingredients (APIs). It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of innovative therapeutic agents.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates targeting a range of therapeutic areas.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Organic Synthesis Building Block: Employed in the construction of complex polyheterocyclic systems due to its fused thienopyridine and benzothiazole motifs.
• Chemical Biology Probes: Potential use in the development of molecular probes for studying biological pathways and target engagement.
• Contract Research & Manufacturing (CRAM): Supplied to organizations providing custom synthesis and process development services for the pharmaceutical industry.

Basic Information

Product Name	Ethyl 2-Amino-3-(1,3-benzothiazol-2-yl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-carboxylate
CAS No.	1105194-36-2
Molecular Formula	C19H17N3O2S2
Molecular Weight	383.49 g/mol
Synonyms	Ethyl 2-amino-3-(benzothiazol-2-yl)-4,7-dihydro-5H-thieno[2,3-c]pyridine-6-carboxylate; 6-Carboxy-2-amino-3-(1,3-benzothiazol-2-yl)-4,7-dihydro-5H-thieno[2,3-c]pyridine ethyl ester; 2-Amino-3-(1,3-benzothiazol-2-yl)-4,7-dihydro-5H-thieno[2,3-c]pyridine-6-carboxylic acid ethyl ester; 1105194-36-2; Thieno[2,3-c]pyridine-6-carboxylic acid derivative
EINECS	Contact for details

Quality Control

Our production of Ethyl 2-Amino-3-(1,3-benzothiazol-2-yl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-carboxylate adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity, essential for research and development applications. All materials are accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We support compliance with cGMP and ISO 9001 standards for pharmaceutical intermediates, and specifications can be tailored to meet specific project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep the container sealed to protect from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Any single impurity ≤ 1.0%
Total Impurities	≤ 3.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.